相关实验视频
Updated: Sep 11, 2025

07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
289
骨质保护素在肺纤维化中升高,并与IPF进展相关:试点研究
Respiration; international review of thoracic diseases
|August 15, 2025
概括
骨质保护蛋白 (OPG) 是由肺纤维细胞产生的,并且随着肺纤维化而增加. 较高的血清OPG水平可能表明异常性肺纤维化 (IPF) 疾病进展.
科学领域:
- 肺部医学 肺部医学
- 纤维化研究 纤维化研究
- 生物标志物发现发现
背景情况:
- 骨质保护素 (OPG) 是一种已知的肝纤维化严重程度的生物标志物.
- 在纤维化肺组织中观察到OPG的产生,但其来源和作用尚不清楚.
- 这项研究调查了OPG的细胞起源和作为肺纤维化中的生物标志物的潜力.
研究的目的:
- 为了确定肺纤维细胞是否产生OPG.
- 评估OPG与肺纤维化进展的关联.
- 评估血清OPG作为异常性肺纤维化 (IPF) 的预后生物标志物.
主要方法:
- 在人类和小鼠纤维化肺组织中检查了OPG表达.
- 研究了人类肺纤维细胞和小鼠精确切割肺切片中的OPG生产.
- 分析了IPF患者和对照者的血清OPG水平,与肺功能相关.
主要成果:
- 在纤维化肺组织 (人类和小鼠) 中,OPG蛋白水平显著升高,与原沉积相关.
- TGFβ刺激增加了小鼠肺切片中的OPG mRNA和蛋白质生产.
- IPF患者的纤维细胞产生更多的OPG;血清OPG水平与肺功能和预测疾病进展有负相关性.
结论:
- 纤维细胞是肺组织中OPG的来源,其产生与纤维化有关.
- 血清OPG可以作为IPF进展的预后生物标志物.
- 需要在更大的队列中进一步验证,以确认OPG在评估纤维化肺部疾病预后中的作用.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
254
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254
Pulmonary Hypertension: Classification and Pathogenesis
287
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
287
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features
521
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
521
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K

